image: Frank Glorius is the winner of the first Springer Heterocyclic Chemistry Award. view more
Credit: Frank Glorius
Springer's new award for outstanding achievement in the field of heterocyclic chemistry has been given to Frank Glorius from the University of Münster, Germany. Glorius is widely recognized as leading the field in terms of originality, impact and versatility among his generation of heterocyclic chemists. The award will be presented in Reading, UK at the European Colloquium on Heterocyclic Chemistry from 13-17 August 2012.
Before becoming a full professor at the University of Münster in 2007, Glorius worked at Harvard University, the Max Planck Institute in Mülheim, and the University of Marburg. His research focuses on C-H activation chemistry, asymmetric arene hydrogenations, organocatalysis, design and application of N-heterocyclic carbenes, metal-organic frameworks and nanoparticles in asymmetric catalysis. In the last two years, he has published an unusually high number of frequently cited articles in high-profile journals.
The Springer Heterocyclic Chemistry Award was created by Springer and the editors of the book series Topics in Heterocyclic Chemistry. The award will be presented every two years and honors outstanding independent academic researchers working in the field of heterocyclic chemistry. The award winner receives a travel grant to attend the European Colloquium on Heterocyclic Chemistry at which he or she will hold a special lecture. In addition, there is a €3,000 cash prize and a lifelong online subscription to Topics in Heterocyclic Chemistry.
Speaking for the series editors, Bert Maes said: "We are very happy that Frank Glorius has been awarded the first Springer Heterocyclic Chemistry Award. His contribution towards the use of transition metals in making heterocycles in an atom-economic and step-efficient way has fundamentally changed the way we think about constructing heterocycles."
The book series Topics in Heterocyclic Chemistry presents critical reviews on heterocyclic compounds dealing with all aspects such as synthesis, reaction mechanisms, fundamental and theoretical studies, biology, pharmacological aspects, applications in material sciences and many more. The overall goal of the series is to cover topics dealing with current trends in heterocyclic chemistry.
Springer Science+Business Media (www.springer.com) is a leading global scientific publisher, providing researchers in academia, scientific institutions and corporate R&D departments with quality content via innovative information products and services. Springer is also a trusted local-language publisher in Europe – especially in Germany and the Netherlands – primarily for physicians and professionals working in the automotive, transport and healthcare sectors. Roughly 2,000 journals and more than 7,000 new books are published by Springer each year, and the group is home to the world's largest STM eBook collection, as well as the most comprehensive portfolio of open access journals. Springer employs nearly 6,000 individuals across the globe and in 2011 generated sales of approximately EUR 890 million.